One of the most important challenges of modern Transplantology can rightly be considered a movement toward the creation of artificial organs for transplantation, in order to relieve the donor service. Artificial organs will lead to the fact that anyone will be able to get damaged organ without waiting in long queues. Not so long ago the staff of the research center of Ulyanovsk state pedagogic University have created a structure similar to human skin. And the “faux leather” in the conventional sense it is not.
The analogue of the skin can easily be used in cosmetics and transplantation is as natural cells, and a number of artificial ingredients. According to the head of the scientific research centre, Ulyanovsk state pedagogical University Elena Antonova,
“We are talking about the so-called tissue-engineered constructs of skin equivalents. We have developed three molecular-cellular products, which can now be used for the treatment of damaged skin, e.g. after burns, mechanical traumas, trophic ulcers, also used in cosmetics”.
The invention of the Ulyanovsk specialists have successfully passed a number of laboratory tests in various clinics of Ulyanovsk, in particular, with the Ulyanovsk regional Oncology center, which operates in the framework of the project on early diagnosis of melanoma and the regional center of specialized medical care. Despite the fact that this skin is not “100% natural”, when transplanting the graft is not rejected and is able to perform all the basic functions natural skin. Moreover, as the researchers note, the analog faux leather simple and relatively cheap to produce, so it will be accessible to a wide range of medical institutions. At this point the inventors plan to obtain a patent for his invention and further cooperation with various medical organizations and rehabilitation centres.
“Our developments in the field of cellular technologies are at the stage of registration of a patent, after which we plan to work more closely with our hospitals and with other regions. We could cooperate with FMBA (Federal medical-biological Agency, approx. edition)”.